About NeuroDiscovery AI
NeuroDiscovery AI is a Technology company based in Alpharetta (United States) founded in 2024. It provides AI-powered datasets and analytics for neurological care and research. It operates on a B2B model. Its Indian entity Neurodiscovery Ai Private Limited reported revenue of ₹5.03 Cr. NeuroDiscovery AI offers products and services including AI Platform, Neurological Datasets, Patient Matching Service, and Biomarker Discovery Tool. Its focus areas include Life Sciences and Biotech, Neurology, Data and Research and AI-Driven Insights. Its competitors include NeuroKaire and Rhaeos; 2 of its 2 listed competitors have raised funding.
Company details
NeuroDiscovery AI compiles extensive neurological datasets, including EHRs and imaging, and applies AI to generate insights for clinical decisions, patient trials, and biomarker discovery. They offer services like patient matching and data analysis to support healthcare providers and biotech firms. Headquartered in Alpharetta, GA, USA, and Bangalore, India, they focus on advancing research in diseases like Parkinsons and Alzheimers.
- Headquarters Alpharetta, United States
- SectorsTechnology
- Email••••••••
- Website neurodiscovery.ai
- Social LinkedIn
- Legal Name Neurodiscovery Ai Private Limited
- Date of Incorporation 29 Jun, 2024
- Jurisdiction Bangalore, Karnataka, India
- Indian entity revenue₹5.03 Cr
FY 2025
- Indian entity net profit₹66,358
FY 2025 · 0% margin
- Indian entity EBITDA₹3.1 Lakh
FY 2025 · 1% margin
Associated legal entities of NeuroDiscovery AI
NeuroDiscovery AI operates through Neurodiscovery Ai Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Neurodiscovery Ai Private Limited CIN U63111KA2024FTC190359 | Active | 29 Jun 2024 | Bangalore, Karnataka | ₹5.0 Cr | 37 | 2 | View details |
Products & Services of NeuroDiscovery AI
NeuroDiscovery AI offers a comprehensive portfolio of products and services, including AI Platform, Neurological Datasets, Patient Matching Service, and Biomarker Discovery Tool.
Delivers insights from data for neurological care decisions
Provides access to patient records and imaging for research
Identifies candidates to streamline trial recruitment
Analyzes data for early diagnosis and therapy development
Board of directors of Neurodiscovery Ai Private Limited (NeuroDiscovery AI)
Neurodiscovery Ai Private Limited is the primary company behind NeuroDiscovery AI. The board of Neurodiscovery Ai Private Limited currently have 2 directors; the longest-serving is Garima Bajoria, appointed in 2024. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Garima Bajoria DIN 10688921 | Director | 29 Jun 2024 | 2 yrs 4 mo | Neurodiscovery Ai Private Limited |
| Divya Veena Sangeetha Matham DIN 10830375 | Director | 14 Feb 2025 | 1 yr 8 mo | Neurodiscovery Ai Private Limited |
Financials of NeuroDiscovery AI
Figures of Neurodiscovery Ai Private Limited, the primary company behind NeuroDiscovery AI, for FY 2025. Revenue was ₹5.03 Cr. Net profit was ₹66,358 (0% margin). EBITDA was ₹3.1 Lakh (1% margin).
- ₹5.03 CrRevenue · FY 2025
- ₹66,358Net profit · 0% margin
- ₹3.1 LakhEBITDA · 1% margin
- ₹10 LakhPaid-up capital
- 37Employees (provident fund records)
Balance sheet, profit and loss, cash flow and ratios of Neurodiscovery Ai Private Limited are on its company page.
Detailed financial statements for NeuroDiscovery AI
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of NeuroDiscovery AI
NeuroDiscovery AI has 2 listed competitors in our database, 2 of them funded. They include NeuroKaire and Rhaeos.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| neurokaire.com | 2017 | Kearny, United States | $20M | Platform offering personalized treatment for psychiatric and neurological conditions | ||
| rhaeos.com | 2018 | Evanston, United States | $12.8M | 10 | Noninvasive device developed for CSF monitoring and hydrocephalus management. |
Detailed competitors of NeuroDiscovery AI
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of NeuroDiscovery AI
The website of NeuroDiscovery AI (neurodiscovery.ai) receives about 4.3K visits a month.
- Monthly visits4.3K
▲ 30.4% vs previous month
Top companies in AI in Life Sciences
3 companies that operate in the same segment as NeuroDiscovery AI (AI in Life Sciences) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Fullpower-AI is recognized as a leading AI-biosensing platform company. | 2003 | Santa Cruz, California, United States | USD 25 M | |||
Drug candidates are optimized via machine learning-enhanced medicinal chemistry. | 2020 | Durham, North Carolina, United States | USD 5.5 M | |||
Live cell imaging solutions are delivered via an AI-based platform. | Wilmington, Delaware, United States |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about NeuroDiscovery AI
NeuroDiscovery AI was founded in 2024.
NeuroDiscovery AI is headquartered in Alpharetta, United States. It is registered at Alpharetta, Georgia, United States.
The primary company behind NeuroDiscovery AI, Neurodiscovery Ai Private Limited, reported revenue of ₹5.03 Cr for FY 2025.
NeuroDiscovery AI compiles extensive neurological datasets, including EHRs and imaging, and applies AI to generate insights for clinical decisions, patient trials, and biomarker discovery. They offer services like patient matching and data analysis to support healthcare providers and biotech firms. Headquartered in Alpharetta, GA, USA, and Bangalore, India, they focus on advancing research in diseases like Parkinsons and Alzheimers.
NeuroDiscovery AI's top competitors include NeuroKaire and Rhaeos.
NeuroDiscovery AI offers AI Platform, Neurological Datasets, Patient Matching Service, and Biomarker Discovery Tool.
NeuroDiscovery AI operates through Neurodiscovery Ai Private Limited.
The legal entities of NeuroDiscovery AI currently have 2 directors, including Divya Veena Sangeetha Matham, Garima Bajoria.